By RICK SMITH
Posted: Mar. 12, 2007
RESEARCH TRIANGLE PARK, N.C. – Stephanie Adams, a patent agent with the King & Spalding law firm in Atlanta since 2002, is the new executive director of the Southeast BIO. (more…)
By Rebecca Kaufman, Counsel, King & Spalding LLP, and Chair, Southeast BIO
In 2005, the $540 million purchase of Emory University’s royalty interest in emtricitabine (Emtriva) was big news. The largest ever deal of its kind for a U.S. university, it brought significant recognition and resources to Emory’s research programs. (more…)
ATLANTA, GA – Atlanta-based Transfusion & Transportation Technologies, Inc., an early-stage spin-out from Emory University that develops specialized automated multi-analyzers and other instrumentation for use in blood centers, was the last company standing at the end of the 2006 Southeastern BIO Investor Forum’s Early-Stage Shootout. (more…)
